CPA advocates for domestic manufacturing of essential generic drugs, personal protective equipment (PPE), and other critical health care products because it is vital for our country’s health security and national security.
COVID-19 showed that in a pandemic, the United States cannot depend on other countries for essential medicines and other medical supplies. Many countries banned exports of them to assure they had enough for their own people.
It is a national security imperative that our country is not dependent on unfriendly nations. At the height of the pandemic, the Chinese Communist Party threatened to withhold essential drugs from America. This threat reveals the inclination by some nations to use medicines as an economic and geopolitical weapon. We must have the capability to manufacture medicines and medical supplies necessary for the country’s public health and survival.
CPA this week applauded the acquisition of Nivagen Pharmaceuticals by member company, PAI Pharma (PAI), of Greenville, SC and Sacramento, CA.
The October trade deficit fell by 39% for goods and services combined, but even the goods deficit fell to monthly numbers not seen in at least five years. The October deficit in goods was $59.14 billion, down 24.5% from September, the Bureau of Economic Analysis said on Thursday.
The current cost-of-living crisis – defined by the soaring cost of essential services – is not the result of excessive consumer demand or short-term inflation shocks. It is the product of decades of trade and industrial policy choices that weakened middle-class wage growth.
CPA welcomed final passage this week of the ‘National Defense Authorization Act (NDAA) for FY2026,’ (S.1071), which has been sent to President Trump’s desk for signature. The legislation advances critical national security priorities, strengthens U.S. defense readiness, raises troop pay by 3.8%, and reinforces the importance of resilient domestic supply chains and robust U.S. manufacturing capacity.
The U.S. goods deficit with China fell by roughly $2 billion in September, coming in at $15.03 billion. China has dropped to fourth place in terms of the countries in which the U.S. has its biggest goods gap.
The affordability crisis is primarily a result of price increases in five major sectors of consumer spending: housing, food, health care, child care, and energy. In none of those sectors are tariffs a significant factor.
